553
Views
8
CrossRef citations to date
0
Altmetric
Clinical features - Review

Association between alopecia areata and thyroid dysfunction

ORCID Icon &
Pages 895-898 | Received 23 May 2021, Accepted 27 Aug 2021, Published online: 06 Sep 2021
 

ABSTRACT

Alopecia Areata is an inflammatory and T cell-mediated autoimmune reaction against unknown autoantigen of hair follicles characterized by patchy, non-scarring loss of hair follicles in the anagen phase. Although its etiology is minimally understood, genetic susceptibility, autoimmunity and stress are thought to be causative factors. It occurs in episodic and recurrent patterns with an incidence rate of 0.1–0.2% in the general population and 7–30 cases per 1000 dermatological patients with a lifetime risk of 1.7%. The lesions can be single and self-limiting or may be widespread. Autoimmune disorders such as Hashimoto’s thyroiditis, Vitiligo, celiac disease, diabetes mellitus, psoriasis ad lupus erythematosus were observed as an associated comorbid disorder in AA patients, but hypothyroidism and Vitiligo have the strongest association. Its clinical course is unpredictable and shows no significant predilection to age, gender or race. AA is a heterogeneous variant of alopecia and has clinical types such as patchy alopecia, alopecia reticularis and alopecia totalis. Various epidemiological reports demonstrate an increased frequency of AA in thyroid disease patients. Contemporary research has shed spotlight on circulating auto-reactive cells in evolution of AA, which may play a role in ultimately linking these diseases. Comprehension of complex interplay between autoantigens and immune cells is still evolving. The present study will explore this association of Alopecia Areata in patients with thyroid dysfunction. This correlation was studied briefly with literature available in the medical database such as PubMed and Google Scholar.

Acknowledgments

The authors have nothing to acknowledge.

Author Contributions

The authors were assigned specific sections to draft; these were developed into a single manuscript which was reviewed and approved by both authors. Named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work, and have given their approval for this version to be published.

Declaration of funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Declaration of financial/other relationships

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Data sharing statement

Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.

Declaration of interest

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.